Article
Gemifloxacin resistance in Mycobacterium tuberculosis without QRDR mutations in gyrA or gyrB: evidence for non-canonical resistance mechanisms.
Microbiology spectrum - 7 Jul 2026
Hekmatpour Niloofar, Hajizadeh Mina, Yousefi Shirin, Marjani Majid, Tarashi Samira, Siadat Seyed Davar
Abstract excerpt
Tuberculosis (TB) remains a global health threat, with multidrug-resistant TB (MDR-TB) presenting major therapeutic challenges. Fluoroquinolones (FQs) are key second-line drugs. Resistance is typically linked to mutations within quinolone resistance-determining regions (QRDRs), though non-canonical mechanisms are increasingly recognized. To evaluate phenotypic susceptibility to gemifloxacin in clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
